This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
In The [...]
Tags:Best Practices·digital strategy·Digital Tools·Education·Opinion·social media·Social network·social networks·strategy·technology·Trends
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Jason Brandt (@jasondmg3)
As Egon [...]
Tags:Best Practices·digital strategy·Digital Tools·Education·Opinion·social media·Social network·social networks·strategy·technology·Trends
by Briana Campbell (@MsMatchGirl)
By now, you’ve all had time to review the FDA’s draft guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices. And you’ve had time to read the multitude of responses that came after (if you didn’t, Fabio Gratton has compiled many of them for you). And, [...]
Tags:electronic media·emerging media·engagement·FDA·FDA Guidance·FDA guidelines·information·innovation·Pharma·Pharmaceutical industry·social media·Social network·strategy·Trends
by DJ Edgerton (@wiltonbound)
The question seems almost nonsensical at first – your Twitter followers may be really outstanding people, but they’re not organic chemists or researchers. And your Facebook fans, while devoted, probably do not, generally speaking, know how to move a new drug through the FDA approval process.
Just the same, it’s a mistake to [...]
Tags:Compliance·data·digital strategy·Digital Tools·Education·engagement·epatient·FDA·information·innovation·Legal Issues·marketing·Pharma·Pharmaceutical industry·R&D·research and development·social media·Social network·strategy·technology·Trends·user needs
by Briana Campbell (@MsMatchGirl)
People like to make out that the issues surrounding pharma’s involvement with social media are extraordinarily complex. I’m not so sure.
It’s over-simplistic – but still true – to say that the main worry with digital media for the pharmaceutical industry is the interactivity of social networks. You see, I don’t think it’s [...]
Tags:Compliance·DTC·Facebook·HIPPAA·marketing·off-label·Pharma·Pharma industry·Pharmaceutical industry·reporting·social media·Social network·Twitter
As we keep talking (and talking and talking) about and waiting (and waiting and waiting) for FDA Guidelines for social media usage, we thought it would be fun to visit this video, from nearly two years ago.
Do you remember this time? Are you still waiting for guidance or are you pushing the boundaries without it?
Tags:FDA·FDA Guidance·FDA guidelines·social media·Social network
by Krissy Goelz (@krisgoelz)
Recently, we were asked what we thought about how Google+ could affect healthcare, by someone who had read an Xconomy post on the same question.
So, does this newest, mega-hyped social network have the potential to really transform the industry? As you’ve seen with our many point/counterpoint articles, we like to [...]
Tags:Digital Tools·Education·engagement·Facebook·Google·Google Plus·Health care·healthcare·innovation·Legal Issues·social media·Social network·Trends·user needs
by Briana Campbell (@MsMatchGirl)
Here’s the question: How do we help people get healthy and stay healthy?
With all the information that’s available, you’d think it would be a no brainer, right? There are warning labels and public service announcements and calories posted at point of purchase. Yet, people seem not to care. When, for instance, was [...]
Tags:Buster Benson·Communities·community·Compliance·gamification·gaming·Health·Health care·Health Month·healthcare·innovation·marketing·Social network·Trends
by Jason Brandt (@jasondmg3)
I don’t understand any of this stuff.
Who has the time to really use this stuff anyway?
No real business can afford to have employees wasting their time on this stuff when they should be busy working.
It’s just a geek thing. Nobody with a life really uses this stuff.
It’s just a kid thing. [...]
Tags:business·communication·Digital Tools·Education·engagement·Facebook·FDA·Health care·healthcare·information·innovation·marketing·Patients·Pharmaceutical industry·social media·Social network·Trends
by DJ Edgerton (@wiltonbound)
What do Lady Gaga, Arnold Schwarzenegger and Charlie Sheen have in common? They’re some of the most popular celebrity masks for party revelers this Halloween season. While industry luminaries may not dress up for tricks and treats, many pharma brands are hiding behind their own masks, limiting the ROI in their digital [...]
